📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Monoclonal Antibody Targeting Sialyl-di-Lewisa-Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development Potential. (2020)

First Author: Tivadar ST

Attributed to: Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-19-0221

PubMed Identifier: 31871270

Publication URI: http://europepmc.org/abstract/MED/31871270

Type: Journal Article/Review

Volume: 19

Parent Publication: Molecular cancer therapeutics

Issue: 3

ISSN: 1535-7163